PRotection by Offering Human papillomavirus Testing on sElf-sampled Cervicovaginal specimens Trial

Completed

• Conditions: Cervical Intraepithelial Neoplasia (CIN), cervix cancer, uterus; Cancer; Cervical cancer

• Registration Number: ISRCTN45527158
• Lead Sponsor: VU University Medical Center (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-12-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 45000

Inclusion Criteria

1. Women invited for the cervical cancer screening program (ages 30 to 60 years), but who are not responding to their invitation as well as their recall (three months after)
2. Residing in the region covered by district health authorities of North Holland and Flevoland (in the Netherlands)

Exclusion Criteria

1. Not called for screening, i.e., ages under 30 years, or over 60 years
2. Actively responded to the invitation or first recall of the cervical screening program by undergoing a cervical smear at the general practitioner
3. Living outside the region covered by district health authorities of North Holland and Flevoland
4. Under follow-up by gynaecologist for previous non-normal cytology, i.e., abnormal cytology and/or CIN three lesion or worse less than two years before inclusion
5. Current pregnancy
6. Status after extirpation of the uterus or amputation of the portio

Study & Design

• Study Type: Interventional
• Study Design: Not specified